Active multiple myeloma is when the disease is causing noticeable symptoms and may be affecting your organs. Common multiple myeloma symptoms include fatigue, bone pain, weakness, and infections.

Transplant candidates are patients who are healthy enough for stronger treatments.  Familiarize yourself with the common active multiple myeloma treatment options below including targeted therapy and then click Create My Conversation Guide to prepare a list of questions to discuss with your doctor.

Xp colored

Loading Your Options...


See If A Clinical Trial Is Right For You or Your Loved One

It is important to learn about clinical trials for your cancer type, their potential benefits, and risks, and then discuss all of your options with your doctors.

Answering a few questions in the Search Tool below will help you find relevant trials by Study Phase: Phase 1, Phase 2, or Phase 3 or by Study Type: Interventional or Observational.

Mobile users, please “X out” or “Accept All Cookies” to begin your search.

video thumbnail
play-icon

Understanding Clinical Trials

Is A Clinical Trial Right For You?

video thumbnail
play-icon

Informed Consent Protects Your Rights

What To Expect When You Participate

Active Multiple Myeloma for Transplant Candidates Treatment Videos

thumb
play-icon

Understanding Myeloma Treatment Types

What are the types of treatment available for myeloma?

thumb
play-icon

What Are the Phases of Myeloma Treatment?

Myeloma specialist Dr. Mark Schroeder explains the phases of myeloma treatment, defining induction, consolidation, and maintenance therapy for patients with myeloma.

thumb
play-icon

Multiple Myeloma: Symptoms, Treatment, and Patient Care

Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell.

thumb
play-icon

Maintenance Therapy

Learn how maintenance therapy can delay myeloma recurrence and improve survival after initial treatment.

thumb
play-icon

Autologous Hematopoietic Stem Cell Transplantation (ASCT)

Learn the risks and benefits of ACST, a key part of a personalized treatment plan for many myeloma patients.